Related Experiment Videos

Histoplasma capsulatum infections of the central nervous system. A clinical review

L J Wheat1, B E Batteiger, B Sathapatayavongs

  • 1Indiana University School of Medicine, Indianapolis.

Medicine
|July 1, 1990
PubMed

Insights

Central nervous system histoplasmosis, including meningitis and mass lesions, affects 10-20% of patients. Amphotericin B is standard, but relapses necessitate long-term monitoring and new antifungals.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Neurology

Background:

  • Disseminated histoplasmosis frequently involves the central nervous system (CNS).
  • Histoplasmosis can present as chronic meningitis or focal CNS lesions mimicking tumors or abscesses.
  • Diagnosis can be challenging, requiring serological tests, cultures, and Histoplasma antigen detection.

Observation:

  • Central nervous system (CNS) involvement occurs in 10-20% of disseminated histoplasmosis cases.
  • Histoplasmosis can cause chronic meningitis, encephalitis, and mass lesions in the brain and spinal cord.
  • Diagnostic methods include serology, cultures, and antigen testing in body fluids.

Findings:

  • Amphotericin B is the primary treatment, but relapses occur in approximately 50% of patients.
  • Long-term follow-up is crucial for detecting relapsing infections.
  • Newer antifungal agents that penetrate the blood-brain barrier are needed.

Implications:

  • Amphotericin B monotherapy without surgery may be effective for cerebral or spinal cord histoplasmomas.
  • Surgical intervention is indicated if clinical abnormalities progress or lesions persist post-treatment.
  • Further research into novel antifungal therapies for CNS histoplasmosis is warranted.

Related Concept Videos